Key Takeaways
- • EQT is pursuing a stake sale in HMI Group, a Singapore-based regional healthcare provider, with the transaction expected to generate approximately $600 million in proceeds at an implied company valuation of around S$1 billion ($721 million).
- • The stake sale represents EQT's partial exit from a healthcare investment in Southeast Asia, demonstrating the firm's active portfolio optimization strategy within its dedicated healthcare buyout platform.
- • EQT's healthcare investment activity remains robust, evidenced by concurrent transactions including its $320 million tender offer to privatize Japan's CareNet (announced August 2025) and its broader healthcare growth strategy targeting scale-up opportunities across Asia.
- • The transaction underscores institutional investor appetite for healthcare assets in the Asia-Pacific region and validates EQT's thesis on regional healthcare consolidation and expansion.
Summary
EQT Partners is exploring the sale of its stake in HMI Group, a Singapore-headquartered regional healthcare provider, in a transaction that could value the company at approximately S$1 billion ($721 million), according to sources familiar with the matter. The proposed stake sale would generate roughly $600 million in proceeds for the Swedish private equity firm, representing a significant realization event within EQT's healthcare portfolio.
HMI Group operates as a multi-national healthcare provider with regional exposure across Southeast Asia, making it an attractive asset for potential acquirers seeking to build or expand healthcare platforms in the high-growth Asia-Pacific market. The company's scale and geographic footprint align with institutional investor appetite for consolidated healthcare operators capable of capturing demographic tailwinds and healthcare spending growth in the region.
The proposed transaction is consistent with EQT's active healthcare dealmaking strategy. The firm recently launched a $320 million tender offer to acquire full ownership of CareNet, Inc., a leading Japanese digital healthcare platform provider, demonstrating EQT's commitment to healthcare acquisitions and consolidation across Asia. EQT's dedicated Healthcare Growth strategy targets companies at the intersection of buyout and venture capital scales, with emphasis on building commercial capabilities, expanding global reach, and enhancing technology infrastructure to drive risk-adjusted returns.
EQT's pursuit of the HMI Group stake sale reflects disciplined capital allocation and portfolio management within a competitive exit environment. Healthcare assets continue to command strong valuations from both strategic and financial buyers, supported by secular growth drivers including aging demographics, rising healthcare expenditure, and digital transformation initiatives across the region. The timing and valuation of the transaction will provide market validation for regional healthcare platform valuations and may influence pricing expectations for comparable healthcare assets in the Asia-Pacific market.
HMI Group operates as a multi-national healthcare provider with regional exposure across Southeast Asia, making it an attractive asset for potential acquirers seeking to build or expand healthcare platforms in the high-growth Asia-Pacific market. The company's scale and geographic footprint align with institutional investor appetite for consolidated healthcare operators capable of capturing demographic tailwinds and healthcare spending growth in the region.
The proposed transaction is consistent with EQT's active healthcare dealmaking strategy. The firm recently launched a $320 million tender offer to acquire full ownership of CareNet, Inc., a leading Japanese digital healthcare platform provider, demonstrating EQT's commitment to healthcare acquisitions and consolidation across Asia. EQT's dedicated Healthcare Growth strategy targets companies at the intersection of buyout and venture capital scales, with emphasis on building commercial capabilities, expanding global reach, and enhancing technology infrastructure to drive risk-adjusted returns.
EQT's pursuit of the HMI Group stake sale reflects disciplined capital allocation and portfolio management within a competitive exit environment. Healthcare assets continue to command strong valuations from both strategic and financial buyers, supported by secular growth drivers including aging demographics, rising healthcare expenditure, and digital transformation initiatives across the region. The timing and valuation of the transaction will provide market validation for regional healthcare platform valuations and may influence pricing expectations for comparable healthcare assets in the Asia-Pacific market.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.